These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11717593)

  • 21. Istaroxime, a novel luso-inotropic agent for the treatment of acute heart failure.
    Wehrens XH
    Curr Opin Investig Drugs; 2007 Sep; 8(9):769-77. PubMed ID: 17729189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of inotropic agents.
    Vroom MB
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):246-52. PubMed ID: 16959760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing patients with rapid atrial fibrillation and decompensated heart failure.
    Al-Habeeb W; Al-Admawi M
    Circ Heart Fail; 2009 Jan; 2(1):71. PubMed ID: 19808317
    [No Abstract]   [Full Text] [Related]  

  • 24. [New positive inotropic drugs].
    Pfaffendorf M
    Med Monatsschr Pharm; 1997 Aug; 20(8):205-17. PubMed ID: 9340466
    [No Abstract]   [Full Text] [Related]  

  • 25. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New CHF drug shown to ease breathing distress among hospitalized patients.
    Clin Resour Manag; 2002 May; 3(5):68-70, 65. PubMed ID: 12048768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic therapies for acutely decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S18-27. PubMed ID: 12439427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inotropic therapy of heart failure. Editorial comments on: Vasodilation and mechanoenergetic inefficiency dominates the effect of the "Ca2+ sensitizer" MCI-154 in intact pigs.
    Duncker DJ; Verdouw PD
    Scand Cardiovasc J; 2002 May; 36(3):131-5. PubMed ID: 12079634
    [No Abstract]   [Full Text] [Related]  

  • 32. Present status of various inotropic agents in heart failure.
    Mittal SR; Maheshwari N
    J Assoc Physicians India; 2001 Nov; 49():1095-9. PubMed ID: 11868865
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of beta-blockers for treatment of cardiac failure].
    Rodríguez Moreno C; Durán Parrondo C; Donado Budiño EG; García Reboredo M; Tato Herrero F; Tarragó Bofarull J; Lado Lado F; Rodríguez López I
    An Med Interna; 2002 Jul; 19(7):368-74. PubMed ID: 12224147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH
    Heart Lung; 2008; 37(3):173-8. PubMed ID: 18482628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Paradoxes of the treatment of cardiac insufficiency].
    Swynghedauw B
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):2003-6. PubMed ID: 2125421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep; 144(35-36):57. PubMed ID: 12380364
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of heart failure with beta-receptor-blockers].
    Schwinger RH
    Dtsch Med Wochenschr; 2002 Mar; 127(13):682-8. PubMed ID: 11928060
    [No Abstract]   [Full Text] [Related]  

  • 40. On equivalence.
    Malik P
    Can J Cardiol; 2003 Aug; 19(9):992. PubMed ID: 12915924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.